Related Experiment Video
Updated: Jun 11, 2025

09:14
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
10.8K
Nirsevimab to reduce infant morbidity from respiratory syncytial virus
Bahaa Abu-Raya1, Joanne M Langley2, Pascal Lavoie2
1Canadian Center for Vaccinology (Abu-Raya, Langley), Dalhousie University, IWK Health Centre and the Nova Scotia Health Authority; Departments of Pediatrics (Abu-Raya, Langley), of Microbiology and Immunology (Abu-Raya), and of Community Health and Epidemiology (Langley), Dalhousie University, Halifax, NS; Department of Pediatrics (Lavoie), University of British Columbia, Vancouver, BC. Bahaa.AbuRaya@dal.ca.
Summary
No abstract available in PubMed .

